Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-22-022742
Filing Date
2022-09-19
Accepted
2022-09-19 17:30:16
Documents
25

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A elph20220914_s1a.htm S-1/A 2342859
2 EXHIBIT 10.25 ex_423646.htm EX-10.25 40940
3 EXHIBIT 10.26 ex_423645.htm EX-10.26 248769
4 EXHIBIT 23.1 ex_424400.htm EX-23.1 3099
5 b01.jpg GRAPHIC 253717
6 b02.jpg GRAPHIC 626045
7 epi01.jpg GRAPHIC 8083
8 ex_423472img001.jpg GRAPHIC 4480
9 ex_423472img002.jpg GRAPHIC 6429
10 i02.jpg GRAPHIC 17460
11 img01.jpg GRAPHIC 21615
12 img02.jpg GRAPHIC 11504
13 img03.jpg GRAPHIC 33677
14 img04.jpg GRAPHIC 26197
15 img05.jpg GRAPHIC 5798
16 img06.jpg GRAPHIC 13043
17 img07.jpg GRAPHIC 7239
18 img08.jpg GRAPHIC 29755
19 img09.jpg GRAPHIC 5909
20 img10.jpg GRAPHIC 13916
21 img11.jpg GRAPHIC 11397
22 img12.jpg GRAPHIC 6815
23 img13.jpg GRAPHIC 6390
24 logo.jpg GRAPHIC 15432
25 logosml.jpg GRAPHIC 2815
  Complete submission text file 0001437749-22-022742.txt   4186807
Mailing Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540 215-554-3530
Eleison Pharmaceuticals Inc (Filer) CIK: 0001880047 (see all company filings)

EIN.: 454373885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-262321 | Film No.: 221251455
SIC: 2834 Pharmaceutical Preparations